{"organizations": [], "uuid": "4595728e1eb40e2e7a03ad84a0bd224d1c421be9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-biocartis-and-amgen-sign-new-agree/brief-biocartis-and-amgen-sign-new-agreement-idUSFWN1P400R", "country": "US", "domain_rank": 408, "title": "BRIEF-Biocartis And Amgen Sign New Agreement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-09T08:15:00.000+02:00", "replies_count": 0, "uuid": "4595728e1eb40e2e7a03ad84a0bd224d1c421be9"}, "author": "", "url": "https://www.reuters.com/article/brief-biocartis-and-amgen-sign-new-agree/brief-biocartis-and-amgen-sign-new-agreement-idUSFWN1P400R", "ord_in_thread": 0, "title": "BRIEF-Biocartis And Amgen Sign New Agreement", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 9 (Reuters) - Biocartis Group Nv:\n* REG-BIOCARTIS GROUP NV: BIOCARTIS AND AMGEN SIGN NEW COMPANION DIAGNOSTIC AGREEMENT FOR NOVEL ONCOLOGY COMPOUND\n* AGREEMENT AIMED AT DEVELOPMENT OF IDYLLA(TM) CDX BIOMARKER TESTS\n* FINANCIAL DETAILS ON NEW CDX AGREEMENT WITH AMGEN ARE NOT DISCLOSED. Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": [], "published": "2018-01-09T08:15:00.000+02:00", "crawled": "2018-01-09T09:42:45.288+02:00", "highlightTitle": ""}